secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2024-01-31T23:59:59+00:00
Accession:  0000950170-24-009086
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Corbus suspends ATM equity offering program, terminates Jan 29 prospectus supplement
--------------------------------------------------------------------------------

- Suspended and terminated the ATM prospectus supplement dated Jan 29, 2024, under Sale Agreement with Jefferies.
- No sales of common stock until a new prospectus supplement is filed.
- The underlying Sale Agreement dated August 6, 2020, remains in full force and effect.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000095017024009086/0000950170-24-009086-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000095017024009086/crbp-20240130.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-009086

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer